Eli Lilly

A groundbreaking drug, Lepodisiran, developed by Eli Lilly, has shown remarkable results in reducing a genetically inherited risk factor for heart disease. According to a recent trial, the experimenta...

In a significant ruling on March 6, 2025, a U.S. judge denied an injunction sought by Eli Lilly to stop compounding pharmacies from producing copies of its weight loss drug, tirzepatide. This decision...